PeakPASI: A new measurement tool in psoriasis care - 07/05/21
Doi : 10.1016/j.jaad.2020.08.096
Linda Tizek, PhD, MPH a, Maximilian Christian Schielein, PhD, MPH a, b, Alexander Zink, MD, MPH, PhD a, ⁎ 
a Technical University of Munich, School of Medicine, Department of Dermatology and Allergy, Munich, Germany
b Karolinska Institutet, Department of Medicine, Karolinska University Hospital, Unit of Dermatology and Venerology, Solna, Sweden
∗Reprint requests: Alexander Zink, MD, MPH, PhD, Technical University of Munich, School of Medicine, Department of Dermatology and Allergy, Biedersteiner Str 29, 80802, Munich, GermanyTechnical University of MunichSchool of MedicineDepartment of Dermatology and AllergyBiedersteiner Str 29Munich80802Germany
| Authors Tizek and Schielein contributed equally to this article. |
|
| Funding sources: Supported in part by an unrestricted research grant by Novartis Pharma GmbH, Germany. |
|
| Disclosure: Author Tizek was financially supported for the presentation of scientific posters and received unrestricted research grants by Novartis Pharma GmbH, Germany. Author Schielein was financially supported for the presentation of scientific posters by and/or received speaker's honoraria from Novartis Pharma GmbH, Germany and Janssen-Cilag, Germany. Dr Zink has been an advisor and/or has received speaker's honoraria and/or received grants and/or participated in clinical trials of the following companies with psoriasis products: AbbVie, Germany; Almirall, Germany; Amgen, Germany; Celgene, Germany; Eli Lilly, Germany; Janssen-Cilag, Germany; Novartis Pharma GmbH, Germany. |
|
| IRB approval status: Reviewed and approved by the local ethics committee of the Medical Faculty of Technical University of Munich (reference 485/17 S). |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 84 - N° 6
P. 1730-1732 - juin 2021 Retour au numéro
Article précédent
- Rural health disparities in melanoma staging and prognostic outcomes in Iowa
- Faraaz S. Zafar, Roshan Abid, Timothy Ginader, Jennifer G. Powers
- Cutaneous signs and risk factors for ocular melanoma
- Katherine Ann McDonald, Hatem Krema, An-Wen Chan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?